Pharmaceutical Drugs Market Global Outlook 2018Including: Cardiovascular Drugs, Musculoskeletal Drugs, Gastrointestinal Drugs, Respiratory Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs, Oncology Drugs, Anti-infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-urinary DrugsCovering: GlaxosmithKline Plc., Bayer AG, Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd, Pfizer Inc., Gilead Sciences, Inc., Johnson & Johnson, Teva Pharmaceuticals, Merck & Co.Europe, Africa, Middle East.
North America was the largest region in the pharmaceutical drugs market in 2017, accounting for around 37% market share. Asia Pacific was the second largest region accounting for around 22% market share. Western Europe was the third largest region accounting for around 20% market share.
Pharmaceutical Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs sector.
Reasons to Purchase
- Fully updated for 2018.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Pharmaceutical Drugs Market Global Briefing 2018 from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.
The market characteristics section of the report defines and explains the market.
The market size section gives the pharmaceutical drugs market revenues, covering both the historic growth of the market and forecasting the future.
Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.
The trends and strategies section highlights the likely future developments in the pharmaceutical drugs market and suggests approaches.
Markets Covered: Cardiovascular Drugs, Musculoskeletal Drugs, Oncology Drugs, Anti-infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-urinary Drugs, Gastrointestinal Drugs, Respiratory Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs.
Companies Mentioned: Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd, Pfizer Inc., Gilead Sciences, Inc., Johnson & Johnson, GlaxosmithKline Plc., Bayer AG, Teva Pharmaceuticals, Merck & Co.
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.